Europe
Silmo Paris and Vision Expo cancelled; 2021 dates announced
The 2020 international optical events calendar has suffered a double blow in recent weeks after the cancellation of some of ...
Drug developer hits major milestone with Lucentis biosimilar
A biopharmaceutical company that is developing cheaper anti-VEGF treatments for major global markets, including Australia, has reported positive results from ...
Novartis AMD drug Beovu secures European approval
European drug regulators have followed in the footsteps of their Australian and US counterparts, following the approval of Novartis’ new ...
Australian CL manufacturer pens long-term deal with Chinese medical firm
Australia’s Capricornia Contact Lens is set to take its specialty products to the lucrative Chinese market after signing a 10-year ...
Commission probes proposed EssilorLuxottica-GrandVision acquisition
EssilorLuxottica has reaffirmed its goal to complete the acquisition of optical retail giant GrandVision within the next 18 months following ...
Novartis targets Europe for next-generation AMD treatment
Novartis’ new therapy for neovascular age-related macular degeneration (nAMD) has advanced part-way through the European regulatory process after winning the ...